Use of Mirvetuximab Soravtansine for Platinum-Resistant Epithelial Ovarian Cancer Patients

Michael J. Birrer, MD, PhD, Director of the University of Alabama at Birmingham Comprehensive Cancer Center gives an overview of his current clinical studies, which focus on the use of mirvetuximab so... Author: ASCO2017 Added: 06/05/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts